Protein Microarrays for Quantitative Detection of PAI-1 in Serum.

about

Prognostic factors of carcinoma of the ampulla of Vater after surgery.

P2860

Q44026501-3F05CD8A-8C2C-4373-BF54-FB046A5F01AC

P2860

Protein Microarrays for Quantitative Detection of PAI-1 in Serum.

Item

http://www.wikidata.org/entity/Q36563164

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Protein Microarrays for Quantitative Detection of PAI-1 in Serum.

@ast

Protein Microarrays for Quantitative Detection of PAI-1 in Serum.

@en

type

Item

label

Protein Microarrays for Quantitative Detection of PAI-1 in Serum.

@ast

Protein Microarrays for Quantitative Detection of PAI-1 in Serum.

@en

prefLabel

Protein Microarrays for Quantitative Detection of PAI-1 in Serum.

@ast

Protein Microarrays for Quantitative Detection of PAI-1 in Serum.

@en

P1476

Protein Microarrays for Quantitative Detection of PAI-1 in Serum.

@en

P2093

Qing-Yun Zhang

http://www.w3.org/2001/XMLSchema#string

Xu Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.

Protein chip technology.

Current status of protein chip development in terms of fabrication and application.

PAI-1 antagonists: predictable indications and unconventional applications.

Protein chips and nanomaterials for application in tumor marker immunoassays.

The effect of anthracycline-based (epirubicin) adjuvant chemotherapy on plasma TAFI and PAI-1 levels in operable breast cancer.

Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.

Development and validation of sandwich ELISA microarrays with minimal assay interference.

Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis.

Protein chip based miniaturized assay for the simultaneous quantitative monitoring of cancer biomarkers in tissue extracts.

P2888

s11670-012-0220-x

P304

220-225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11670-012-0220-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23358703

http://www.w3.org/2001/XMLSchema#string

P932

3555280

http://www.w3.org/2001/XMLSchema#string

Protein Microarrays for Quantitative Detection of PAI-1 in Serum.

about

P2860

P2860

Protein Microarrays for Quantitative Detection of PAI-1 in Serum.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932